NCT06228066 2026-03-17Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)National Institutes of Health Clinical Center (CC)Phase 2 Recruiting45 enrolled
NCT03228667 2026-01-14QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsImmunityBio, Inc.Phase 2 Active not recruiting40 enrolled